Trazodone

This classification denotes an antidepressant agent with the molecular formula C19H22ClN5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YBK48BXK30, chemically known as 1,2,4-triazolo(4,3-a)pyridin-3(2h)-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)- but generally known as trazodone, which bears US NIH Compound Identifier 5533. European Medicines Agency schedules Trazodone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11224MIG. The term TRAZODONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules trazodone in its Anatomical Therapeutic Chemical (ATC) Classification. TRAZODONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule trazodone under HS 29335995 and SITC 51576. As of Q4 2014, TRAZODONE remains the US FDA Preferred Term for this commodity. Trazodone bears US NLM identifiers UMLS ID C0040805 and NCI Concept Code C29510. SMILES: Clc1cc(N2CCN(CC2)CCCn2nc3n(c2=O)cccc3)ccc1.